Target intelligence / Profile preview

OTU domain-containing protein 4 (OTUD4)

Target
OTUD4
Molecular classification
Enzyme, Deubiquitinase (DUB), OTU (ovarian tumor) family, RNA-binding protein
01

Overview

OTU domain-containing protein 4 (OTUD4) is a cytoplasmic deubiquitinating enzyme belonging to the OTU protease family. It specifically cleaves K48-linked ubiquitin chains on proteins, stabilizing substrates involved in DNA repair, translation, and stress responses. OTUD4 forms part of neuronal RNA transport granules and is recruited to stress granules under cellular stress, where it regulates granule formation and local protein synthesis. Its depletion results in defective stress granule formation and increased apoptosis. OTUD4 plays crucial roles in regulating translation, TGFβ signaling, and cell proliferation. Mutations and altered expression of OTUD4 are linked to neurodegenerative diseases such as ALS and dementia, rare genetic disorders (Gordon Holmes syndrome), and several cancers including glioblastoma, where it promotes tumor progression through stabilization of CDK1 and enhancement of MAPK pathway signaling. OTUD4 primarily acts as a scaffold for other DUBs, such as USP7 and USP9X, to regulate DNA alkylation damage repair proteins such as ALKBH2/ALKBH3, with its catalytic activity sometimes dispensable for function.

Other names
OTUD4HIN-1KIAA1046HSHIN1DUBA6HIV-1-induced protein HIN-1HIN1
02

Mechanism of action

Drugs targeting OTUD4 would be expected to inhibit its deubiquitinase activity, destabilize key substrates, and sensitize cells to stress or DNA alkylating agents

03

Biological functions

Regulation of translationStress granule formation and maintenanceRNA transportDNA alkylation damage responseRegulation of NF-κB signalingTGFβ pathway regulationCell proliferation
04

Disease associations

Cancer (including glioblastoma)Neurodegenerative disease (ALS, FTD)DNA damage resistance and repairGordon Holmes syndrome (rare neuroendocrine disorder with ataxia, dementia, hypogonadism)
05

Safety considerations

Potential for apoptosis if OTUD4 is inhibited or lost in non-target tissues (since knockdown leads to cell death)Potential neurotoxicity or reproductive effects given its association with neurodegeneration and hypogonadism in genetic disordersCell proliferation and cancer risk if upregulated
06

Biomarkers

OTUD4 overexpression (especially in glioblastoma and other cancers)OTUD4 mutation (diagnostic in Gordon Holmes syndrome)

Beyond the preview

Go deeper on OTU domain-containing protein 4 (OTUD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OTU domain-containing protein 4 (OTUD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call